Glaxosmithkline: Royal Bank of Canada’s Largest Q3 Healthcare Stock Position

Wall St. Watchdog reveals information regarding Royal Bank of Canada’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 441 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $3.29 billion.

  • Glaxosmithkline Plc (NYSE:GSK): On 06/30/2011, Royal Bank of Canada reported holding 13,555,991 shares with a market value of $581,552,035. This comprised 0.58% of the total portfolio. On 09/30/2011, Royal Bank of Canada reported holding 16,918,261 shares with a market value of $698,555,012. This comprised 0.88% of the total portfolio. The net change in shares for this position over the two quarters is 3,362,270. About Company: GlaxoSmithKline plc is a research-based pharmaceutical group that develops, manufactures and markets vaccines, prescription and over-the-counter medicines, as well as health-related consumer products. The Group, which also provides laboratory testing and disease management services, specializes in treatments for respiratory, central nervous system, gastro-intestinal and genetic disorders
  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, Royal Bank of Canada reported holding 6,288,766 shares with a market value of $418,328,693. This comprised 0.41% of the total portfolio. On 09/30/2011, Royal Bank of Canada reported holding 4,923,983 shares with a market value of $313,608,471. This comprised 0.4% of the total portfolio. The net change in shares for this position over the two quarters is -1,364,783. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, Royal Bank of Canada reported holding 21,827,469 shares with a market value of $449,645,870. This comprised 0.44% of the total portfolio. On 09/30/2011, Royal Bank of Canada reported holding 16,888,028 shares with a market value of $298,580,340. This comprised 0.38% of the total portfolio. The net change in shares for this position over the two quarters is -4,939,441. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Valeant Pharmaceuticals International (NYSE:VRX): On 06/30/2011, Royal Bank of Canada reported holding 6,934,453 shares with a market value of $360,314,172. This comprised 0.36% of the total portfolio. On 09/30/2011, Royal Bank of Canada reported holding 4,358,558 shares with a market value of $161,789,668. This comprised 0.2% of the total portfolio. The net change in shares for this position over the two quarters is -2,575,895. About Company: Valeant Pharmaceuticals International, Inc. develops and distributes drugs. The Company develops drugs for unmet medical needs in central nervous system disorders; and distributes generic and branded generic drugs in Latin America and Eastern Europe.
  • Unitedhealth Group Inc. (NYSE:UNH): On 06/30/2011, Royal Bank of Canada reported holding 3,725,770 shares with a market value of $192,175,223. This comprised 0.19% of the total portfolio. On 09/30/2011, Royal Bank of Canada reported holding 3,262,147 shares with a market value of $150,450,216. This comprised 0.19% of the total portfolio. The net change in shares for this position over the two quarters is -463,623. About Company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.
  • Merck & Co. Inc. (NYSE:MRK): On 06/30/2011, Royal Bank of Canada reported holding 6,370,671 shares with a market value of $224,820,985. This comprised 0.22% of the total portfolio. On 09/30/2011, Royal Bank of Canada reported holding 4,461,575 shares with a market value of $145,893,506. This comprised 0.18% of the total portfolio. The net change in shares for this position over the two quarters is -1,909,096. About Company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Abbott Laboratories (NYSE:ABT): On 06/30/2011, Royal Bank of Canada reported holding 3,616,195 shares with a market value of $190,284,177. This comprised 0.19% of the total portfolio. On 09/30/2011, Royal Bank of Canada reported holding 2,806,919 shares with a market value of $143,545,836. This comprised 0.18% of the total portfolio. The net change in shares for this position over the two quarters is -809,276. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Alexion Pharmaceuticals Inc. (NASDAQ:ALXN): On 06/30/2011, Royal Bank of Canada reported holding 1,403,708 shares with a market value of $66,016,386. This comprised 0.07% of the total portfolio. On 09/30/2011, Royal Bank of Canada reported holding 1,274,860 shares with a market value of $81,667,528. This comprised 0.1% of the total portfolio. The net change in shares for this position over the two quarters is -128,848. About Company: Alexion Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops proprietary immunoregulatory compounds for the treatment of autoimmune and cardiovascular diseases. The Company develops C5 complement inhibitors and Apogens which are two classes of potential therapeutic compounds designed to selectively target specific disease-causing segments of the immune system.
  • Bristol-myers Squibb Company (NYSE:BMY): On 06/30/2011, Royal Bank of Canada reported holding 3,255,420 shares with a market value of $94,276,960. This comprised 0.09% of the total portfolio. On 09/30/2011, Royal Bank of Canada reported holding 2,507,577 shares with a market value of $78,687,764. This comprised 0.1% of the total portfolio. The net change in shares for this position over the two quarters is -747,843. About Company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
  • Amgen Inc. (NASDAQ:AMGN): On 06/30/2011, Royal Bank of Canada reported holding 1,536,067 shares with a market value of $89,629,507. This comprised 0.09% of the total portfolio. On 09/30/2011, Royal Bank of Canada reported holding 1,194,533 shares with a market value of $65,651,533. This comprised 0.08% of the total portfolio. The net change in shares for this position over the two quarters is -341,534. About Company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.

(Note: Data regarding Royal Bank of Canada’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet